Kiran Musunuru, MD, PhD, MPH

faculty photo
Associate Professor of Medicine
Department: Medicine
Graduate Group Affiliations

Contact information
3400 Civic Center Blvd, Bldg 421
11-104 Smilow Center for Translational Research
Philadelphia, PA 19104
Office: 215-573-4717
Education:
AB (Biochemical Sciences)
Harvard College, Cambridge, MA, 1997.
PhD (Biomedical Sciences)
The Rockefeller University, New York, NY, 2003.
MD (Medicine)
Weill-Cornell Medical College, New York, NY, 2004.
MPH (Epidemiology)
Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, 2009.
Permanent link
 
> Perelman School of Medicine   > Faculty   > Details

Selected Publications

Rohacek Alex M, Bebee Thomas W, Tilton Richard K, Radens Caleb M, McDermott-Roe Chris, Peart Natoya, Kaur Maninder, Zaykaner Michael, Cieply Benjamin, Musunuru Kiran, Barash Yoseph, Germiller John A, Krantz Ian D, Carstens Russ P, Epstein Douglas J: ESRP1 Mutations Cause Hearing Loss due to Defects in Alternative Splicing that Disrupt Cochlear Development. Developmental cell 43(3): 318-331.e5, Nov 2017.

Wang X, Raghavan A, Peters DT, Pashos EE, Rader DJ, Musunuru K.: Interrogation of the Atherosclerosis-Associated SORT1 (Sortilin 1) Locus With Primary Human Hepatocytes, Induced Pluripotent Stem Cell-Hepatocytes, and Locus-Humanized Mice. Arteriosclerosis, thrombosis, and vascular biology Nov 2017 Notes: Epub ahead of print.

Musunuru K; Lagor WR; Miano JM: What Do We Really Think About Human Germline Genome Editing, and What Does It Mean for Medicine? Circulation: Cardiovascular genetics 10(5): e001910, Oct 2017.

Liu DJ, Peloso GM, Yu H, Butterworth AS, Wang X, Mahajan A, Saleheen D, Emdin C, Alam D, Alves AC, Amouyel P, Di Angelantonio E, Arveiler D, Assimes TL, Auer PL, Baber U, Ballantyne CM, Bang LE, Benn M, Bis JC, Boehnke M, Boerwinkle E, Bork-Jensen J, Bottinger EP, Brandslund I, Brown M, Busonero F, Caulfield MJ, Chambers JC, Chasman DI, Chen YE, Chen YI, Chowdhury R, Christensen C, Chu AY, Connell JM, Cucca F, Cupples LA, Damrauer SM, Davies G, Deary IJ, Dedoussis G, Denny JC, Dominiczak A, Dubé MP, Ebeling T, Eiriksdottir G, Esko T, Farmaki AE, Feitosa MF, Ferrario M, Ferrieres J, Ford I, Fornage M, Franks PW, Frayling TM, Frikke-Schmidt R, Fritsche LG, Frossard P, Fuster V, Ganesh SK, Gao W, Garcia ME, Gieger C, Giulianini F, Goodarzi MO, Grallert H, Grarup N, Groop L, Grove ML, Gudnason V, Hansen T, Harris TB, Hayward C, Hirschhorn JN, Holmen OL, Huffman J, Huo Y, Hveem K, Jabeen S, Jackson AU, Jakobsdottir J, Jarvelin MR, Jensen GB, Jørgensen ME, Jukema JW, Justesen JM, Kamstrup PR, Kanoni S, Karpe F, Kee F, Khera AV, Klarin D, Koistinen HA, Kooner JS, Kooperberg C, Kuulasmaa K, Kuusisto J, Laakso M, Lakka T, Langenberg C, Langsted A, Launer LJ, Lauritzen T, Liewald DCM, Lin LA, Linneberg A, Loos RJF, Lu Y, Lu X, Mägi R, Malarstig A, Manichaikul A, Manning AK, Mäntyselkä P, Marouli E, Masca NGD, Maschio A, Meigs JB, Melander O, Metspalu A, Morris AP, Morrison AC, Mulas A, Müller-Nurasyid M, Munroe PB, Neville MJ, Nielsen JB, Nielsen SF, Nordestgaard BG, Ordovas JM, Mehran R, O'Donnell CJ, Orho-Melander M, Molony CM, Muntendam P, Padmanabhan S, Palmer CNA, Pasko D, Patel AP, Pedersen O, Perola M, Peters A, Pisinger C, Pistis G, Polasek O, Poulter N, Psaty BM, Rader DJ, Rasheed A, Rauramaa R, Reilly DF, Reiner AP, Renström F, Rich SS, Ridker PM, Rioux JD, Robertson NR, Roden DM, Rotter JI, Rudan I, Salomaa V, Samani NJ, Sanna S, Sattar N, Schmidt EM, Scott RA, Sever P, Sevilla RS, Shaffer CM, Sim X, Sivapalaratnam S, Small KS, Smith AV, Smith BH, Somayajula S, Southam L, Spector TD, Speliotes EK, Starr JM, Stirrups KE, Stitziel N, Strauch K, Stringham HM, Surendran P, Tada H, Tall AR, Tang H, Tardif JC, Taylor KD, Trompet S, Tsao PS, Tuomilehto J, Tybjaerg-Hansen A, van Zuydam NR, Varbo A, Varga TV, Virtamo J, Waldenberger M, Wang N, Wareham NJ, Warren HR, Weeke PE, Weinstock J, Wessel J, Wilson JG, Wilson PWF, Xu M, Yaghootkar H, Young R, Zeggini E, Zhang H, Zheng NS, Zhang W, Zhang Y, Zhou W, Zhou Y, Zoledziewska M; Charge Diabetes Working Group; EPIC-InterAct Consortium; EPIC-CVD Consortium; GOLD Consortium; VA Million Veteran Program, Howson JMM, Danesh J, McCarthy MI, Cowan CA, Abecasis G, Deloukas P, Musunuru K, Willer CJ, Kathiresan S.: Exome-wide association study of plasma lipids in >300,000 individuals. Nature genetics Oct 2017 Notes: Epub ahead of print.

Chadwick AC; Wang X; Musunuru K: In Vivo Base Editing of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) as a Therapeutic Alternative to Genome Editing. Arteriosclerosis, thrombosis, and vascular biology 37(9): 1741-1747, Sep 2017.

Chadwick AC; Musunuru K: CRISPR-Cas9 Genome Editing for Treatment of Atherogenic Dyslipidemia. Arteriosclerosis, thrombosis, and vascular biology Aug 2017.

Musunuru K; Ingelsson E; Fornage M; Liu P; Murphy AM; Newby LK; Newton-Cheh C; Perez MV; Voora D; Woo D: The Expressed Genome in Cardiovascular Diseases and Stroke: Refinement, Diagnosis, and Prediction: A Scientific Statement From the American Heart Association. Circulation: Cardiovascular genetics 10(4): e000037, Aug 2017.

Ormond KE; Mortlock DP; Scholes DT; Bombard Y; Brody LC; Faucett WA; Garrison N; Hercher L; Isasi R; Middleton A; Musunuru K; Shriner D; Virani A; Young CE: Human Germline Genome Editing. American journal of human genetics 101(2): 167-176, Aug 2017.

Chadwick AC; Musunuru K: Treatment of Dyslipidemia Using CRISPR/Cas9 Genome Editing. Current atherosclerosis reports 19(7): 32, Jul 2017.

Musunuru K; Kathiresan S: Cardiovascular endocrinology: Is ANGPTL3 the next PCSK9? Nature reviews. Endocrinology Jul 2017.

back to top
Last updated: 11/16/2017
The Trustees of the University of Pennsylvania